Skip to main content
. 2020 Sep 17;19(7):1469–1479.e19. doi: 10.1016/j.cgh.2020.09.027

Supplementary Figure 5.

Supplementary Figure 5

Etiology of CLD among patients with COVID-19. (A) Prevalence of different etiologies of CLD in patients with COVID-19. (B) Stage of CLD in patients with COVID-19. AIH, autoimmune hepatitis; ALD, alcohol-related liver disease; CC, cholangiocarcinoma; CLD, chronic liver disease; COVID-19, coronavirus disease 2019; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.